Oxalo Therapeutics, Inc. — Form D

Oxalo Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-06. $250K was reported sold. Industry: Other Technology.

Offering

• Filed: 2018-06-06
• Form: D
• Accession: 0001740010-18-000002
• Industry: Other Technology
• Exemptions: 06b
• Amount sold: $250K
• Minimum investment: $1
• Investors: 1
• Date of first sale: 2018-06-05
• Revenue range: Decline to Disclose
• SEC file number: 021-313980

Issuer

• Name: Oxalo Therapeutics, Inc.
• CIK: 0001739172
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 1452 EAST 53RD STREET, CHICAGO, IL, 60615
• Phone: 312-906-5342

Officers, directors & promoters (3)

More

• CIK 1739172 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search